Markus H. Weissbach

Markus H. Weissbach

Directeur des opérations chez
Dignity Sciences Ltd.
70 ans
Health Technology
Commercial Services
Consumer Services

Profil

Markus H.
Weissbach
is the founder of EHCOR Consult GmbH, which was founded in 2003.
He held the title of Managing Director in 2004.
Dr. Weissbach's current job is as Chief Operating Officer & Medical Director at Dignity Sciences Ltd. Dr. Weissbach's former jobs include being the President & Chief Executive Officer at Hesperion AG from 2004 to 2007, Chief Medical Officer & Executive Chairman at Averion International Corp.
in 2010, International Medical Director at Knoll AG, Associate Director-Clinical Cardiology at BASF Pharma Ltd. in 1994, Director-Clinical Research at Takeda Europe Research & Development Centre from 1994 to 1996, and President-Europe at ICON plc from 1996 to 2003.
He was also a Member-Supervisory Board at bioXXmed AG and Chief Medical Officer-Europe at GSK Vaccines GmbH.
Dr. Weissbach received a doctorate degree from the University of Freiburg in 1982.

Postes actifs de Markus H. Weissbach

SociétésPosteDébut
Directeur des opérations -

Anciens postes connus de Markus H. Weissbach

SociétésPosteFin
BIOXXMED AG Directeur Technique/Scientifique/R&D 21/10/2016
President 31/10/2007
EHCOR Consult GmbH
Fondateur 01/09/2004
ICON PUBLIC LIMITED COMPANY Corporate Officer/Principal 01/01/2003
Directeur Technique/Scientifique/R&D 01/01/1996
Voir l'expérience en détail de Markus H. Weissbach

Formation de Markus H. Weissbach

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

34

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées11

Commercial Services

Consumer Services

Health Technology

Health Technology

Commercial Services

Commercial Services

Health Technology

EHCOR Consult GmbH

Commercial Services

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Markus H. Weissbach
DERNIÈRES HEURES | -40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT